$37.58
$-9.24 (-18.90%)
End-of-day quote: 09/17/2022
NasdaqGS:TWST

Twist Bioscience (TWST)

Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products.

If you are interested in TWST stock information, you might also be interested in competitors like NasdaqGS:GH.

With a P/E ratio of 0.00, the stock appears relatively cheap compared to its index ^SPX at the moment.

The market capitalization of Twist Bioscience is currently at $2.12 B. This places it among the medium capitalized companies.

The book value reported in the balance sheet results in a P/B ratio of 2.45.

With one share of Twist Bioscience investors achieved a dividend of $0.00. This results in a very low dividend yield of 0.00%.

For the risk analysis, the high beta factor should be noted, which is currently at a value of 1.11. The price of the stock NasdaqGS:TWST is therefore subject to relatively strong fluctuations in relation to the overall market.

4.12% of TWST Stocks is owned by insiders.

For Wall Street analysts, a price target of $111.83 is currently considered realistic.

NasdaqGS:TWST has a 52 week range of $25.07 - $139.99 and is currently trading around $37.58.

The high short sale ratio indicated that the value might decrease in the foreseeable future.

0
Underperform
1
2
3
4
5
6
7
8
9
10
1M 3M YTD 1Y 2Y 5Y 10Y 20Y
P/E Ratio
0.0
Market Cap
2.12B
LT Debt/Cap
0.01%
Price-to-book Ratio
2.45
Earnings
11/22/2022
Dividend
$0.00
Div Yld
0.00%
Dividend Growth
0 Years
Beta
1.11
Short Interest
11.34%
Forecast 1Y
0.00%
Analyst Price Target
$111.83
LTG 5Y
-10.22%
52 week range
$25.07 - $139.99